Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Le Tien

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Eye (London, England)|February 13, 2010
Ranibizumab for retinal angiomatous proliferation in age-related macular degenerationK Atmani, M Voigt, V Le Tien, et al.
Journal Francais D'Ophtalmologie|September 22, 2006
[SPA-1: semiology for phenotyping AMD: precursors]V Le Tien, E Souied, P d'Athis, et al.
Journal Francais D'Ophtalmologie|February 2, 2011
[SPA-2: semiology for phenotyping AMD: atrophic AMD]R Tahiri Joutei Hassani, V Le Tien, F Canoui-Poitrine, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Eye (London, England)|February 13, 2010
Ranibizumab for retinal angiomatous proliferation in age-related macular degenerationK Atmani, M Voigt, V Le Tien, et al.
Journal Francais D'Ophtalmologie|September 22, 2006
[SPA-1: semiology for phenotyping AMD: precursors]V Le Tien, E Souied, P d'Athis, et al.
Journal Francais D'Ophtalmologie|February 2, 2011
[SPA-2: semiology for phenotyping AMD: atrophic AMD]R Tahiri Joutei Hassani, V Le Tien, F Canoui-Poitrine, et al.
Pageof 1